immunotherapy

Step closer race run
Biotech

Immutep's LAG-3 agent posts 'impressive' survival data

Immutep suggests that a high unmet need for first-line, PD-L1-negative HNSCC could potentially pave eftilagimod a path to approval.
Angus Liu May 5, 2025 10:37am
Court lawsuit legal litigation

Biocon accused of IP theft to create cancer biotech Bicara

Oct 24, 2024 11:04am
christmas cash gift money present holiday

UCLA scoops $120M gift for immunology and immunotherapy site

Aug 28, 2024 9:25am
Genentech

Genentech to close cancer immunology research department

Aug 16, 2024 11:08am
artificial intelligence chip

AI model from NIH, MSKCC predicts immunotherapy responses: study

Jun 4, 2024 12:42pm
An artists concept of chains of amino acides called peptides which together make up polypeptides or proteins

New immunotherapy drug design ups survival in mice with cancer

Apr 23, 2024 3:40am